Onyx Bridge Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$271K Buy
518
+87
+20% +$44.5K 0.02% 335
2026
Q2
$214K Sell
431
-63
-13% -$27.9K 0.02% 356
2026
Q1
$221K Buy
494
+3
+0.6% +$1.4K 0.02% 331
2025
Q4
$223K Buy
+491
New +$212K 0.02% 323
2024
Q4
– Sell
-724
Closed -$337K – 302
2024
Q3
$337K Buy
+724
New +$348K 0.05% 203

Other funds holding VRTX

Onyx Bridge Wealth Group's VRTX Position: Q3 2026 in Review

Onyx Bridge Wealth Group increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q3 2026, buying an estimated $44.5K and bringing the position to 518 shares worth $271K. The position accounts for 0.02% of the portfolio, ranked #335.

Onyx Bridge Wealth Group first reported a position in VRTX in Q3 2024 and has held it in 5 quarters since. The position peaked at $337K in Q3 2024. 1,772 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Onyx Bridge Wealth Group held 518 shares of Vertex Pharmaceuticals worth $271K as of Q3 2026.
  • Onyx Bridge Wealth Group bought 87 Vertex Pharmaceuticals shares in Q3 2026, an estimated $44.5K.
  • Vertex Pharmaceuticals made up 0.02% of Onyx Bridge Wealth Group's portfolio in Q3 2026, its #335 holding.
  • Onyx Bridge Wealth Group first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Onyx Bridge Wealth Group's Vertex Pharmaceuticals position peaked at $337K in Q3 2024.
  • 1,772 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q3 2026, filed 16 Oct 2026.